Related Experiment Video
Updated: Jun 28, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Novel targets for antidepressant therapies
Paul E Holtzheimer1, Charles B Nemeroff
1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle Northeast, Suite 4000, Atlanta, GA 30322, USA. pholtzh@emory.edu
Current Psychiatry Reports
|November 5, 2008
Summary
Many patients do not achieve depression remission with standard treatments. Novel therapies targeting neurobiology, including new medications and brain stimulation techniques, offer improved antidepressant treatment options.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Many patients with depression do not respond to current antidepressant monotherapy.
- A significant portion of patients show limited improvement even with aggressive treatment strategies.
Purpose of the Study:
- To review novel therapeutic targets for improved antidepressant therapies.
- To explore advancements in pharmacologic and neuromodulation approaches for depression.
Main Methods:
- Review of emerging antidepressant targets and treatment modalities.
- Categorization of novel approaches into monoaminergic optimization, non-monoamine neurotransmitter targeting, and direct neuronal modulation.
Main Results:
- Identified novel pharmacologic targets: triple monoamine reuptake inhibitors, dopamine receptor agonists, CRF-1 antagonists, glucocorticoid receptor antagonists, substance P antagonists, NMDA antagonists, nemifitide, omega-3 fatty acids, and melatonin agonists.
- Highlighted advancements in focal brain stimulation: vagus nerve stimulation, TMS, MST, tDCS, and DBS.
Conclusions:
- Significant progress in understanding depression neurobiology has led to diverse novel therapeutic targets.
- Future antidepressant therapies will likely involve optimized monoaminergic modulation, novel neurotransmitter systems, and direct brain stimulation techniques.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...